| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.005 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.093 | 0.005 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.006 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.099 | 0.006 |